TVTX – travere therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress [Yahoo! Finance]
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
Travere Therapeutics to Present at Upcoming Investor Conferences
Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Form 10-Q Travere Therapeutics, For: Mar 31
Form 8-K Travere Therapeutics, For: May 06
Form SC 13G Travere Therapeutics, Filed by: Rock Springs Capital Management LP
Form 8-K Travere Therapeutics, For: Apr 24
Form 4 Travere Therapeutics, For: Apr 11 Filed by: Cline Christopher R.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.